Barclays’s Tyra Biosciences TYRA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $589K | Buy |
61,555
+19,044
| +45% | +$182K | ﹤0.01% | 2955 |
|
|
2025
Q1 | $395K | Sell |
42,511
-559
| -1% | -$5.19K | ﹤0.01% | 2974 |
|
|
2024
Q4 | $599K | Buy |
43,070
+5,445
| +14% | +$75.7K | ﹤0.01% | 2947 |
|
|
2024
Q3 | $884K | Buy |
37,625
+25,106
| +201% | +$590K | ﹤0.01% | 2690 |
|
|
2024
Q2 | $201K | Buy |
12,519
+2,669
| +27% | +$42.9K | ﹤0.01% | 3050 |
|
|
2024
Q1 | $161K | Sell |
9,850
-9,377
| -49% | -$153K | ﹤0.01% | 3446 |
|
|
2023
Q4 | $266K | Buy |
19,227
+16,721
| +667% | +$231K | ﹤0.01% | 3380 |
|
|
2023
Q3 | $34K | Sell |
2,506
-282
| -10% | -$3.83K | ﹤0.01% | 3746 |
|
|
2023
Q2 | $48K | Sell |
2,788
-3,997
| -59% | -$68.8K | ﹤0.01% | 3694 |
|
|
2023
Q1 | $109K | Buy |
6,785
+3,204
| +89% | +$51.5K | ﹤0.01% | 3476 |
|
|
2022
Q4 | $27K | Buy |
3,581
+3,025
| +544% | +$22.8K | ﹤0.01% | 3969 |
|
|
2022
Q3 | $5K | Sell |
556
-102
| -16% | -$917 | ﹤0.01% | 4382 |
|
|
2022
Q2 | $5K | Sell |
658
-1,257
| -66% | -$9.55K | ﹤0.01% | 4481 |
|
|
2022
Q1 | $20K | Buy |
+1,915
| New | +$20K | ﹤0.01% | 4335 |
|